nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma
|
Shigeta, Keisuke |
|
|
3 |
6 |
p. 756-763 |
artikel |
2 |
Contents
|
|
|
|
3 |
6 |
p. iii-v |
artikel |
3 |
Corrigendum to ‘Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis’ [European Urology Oncology 3 (2020) 306-315]
|
Woo, Sungmin |
|
|
3 |
6 |
p. 811 |
artikel |
4 |
Cutting-edge Management of Muscle-invasive Bladder Cancer in 2020 and a Glimpse into the Future
|
Vetterlein, Malte W. |
|
|
3 |
6 |
p. 789-801 |
artikel |
5 |
Do Learning Disabilities Affect Testicular Cancer Survival: A National Cohort Study Between 2001 and 2015
|
Afshar, Mehran |
|
|
3 |
6 |
p. 773-779 |
artikel |
6 |
Early Tolerance and Tumor Control Outcomes with High-dose Ultrahypofractionated Radiation Therapy for Prostate Cancer
|
Zelefsky, Michael J. |
|
|
3 |
6 |
p. 748-755 |
artikel |
7 |
Editorial Board
|
|
|
|
3 |
6 |
p. i-ii |
artikel |
8 |
Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals
|
Forde, Claire |
|
|
3 |
6 |
p. 764-772 |
artikel |
9 |
Opening a Scan of Worms
|
Davis, Ian D. |
|
|
3 |
6 |
p. 725-727 |
artikel |
10 |
Patterns of Cancer Progression of Metastatic Hormone-sensitive Prostate Cancer in the ECOG3805 CHAARTED Trial
|
Bryce, Alan H. |
|
|
3 |
6 |
p. 717-724 |
artikel |
11 |
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging–targeted Biopsy
|
Gandaglia, Giorgio |
|
|
3 |
6 |
p. 739-747 |
artikel |
12 |
Quality Assessment of Intraoperative Adverse Event Reporting During 29 227 Robotic Partial Nephrectomies: A Systematic Review and Cumulative Analysis
|
Cacciamani, Giovanni E. |
|
|
3 |
6 |
p. 780-783 |
artikel |
13 |
Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder
|
Rouanne, Mathieu |
|
|
3 |
6 |
p. 728-738 |
artikel |
14 |
Re: Ashley M. Hopkins, Ganessan Kichenadasse, Christos S. Karapetis, et al. Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab. Clin Cancer Res. In press. https://doi.org/10.1158/1078-0432.CCR-20-1876
|
Funada, Satoshi |
|
|
3 |
6 |
p. 807-808 |
artikel |
15 |
Re: Karl H. Tully, David-Dan Nguyen, Peter Herzog, et al. Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2019.08.003
|
Fragkoulis, Charalampos |
|
|
3 |
6 |
p. 809-810 |
artikel |
16 |
Re: Madhuri Koti, Molly A. Ingersoll, Shilpa Gupta, et al. Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment. Eur Urol Oncol 2020;3:622–30
|
Alfano, Massimo |
|
|
3 |
6 |
p. 802-803 |
artikel |
17 |
Re: Maha Hussain, Joaquin Mateo, Karim Fizazi, et al. Survival with Olaparib in Metastatic Castration-resistant Prostate Cancer. N Engl J Med. In press. https://doi.org/10.1056/NEJMoa2022485
|
Rizzo, Alessandro |
|
|
3 |
6 |
p. 806 |
artikel |
18 |
Re: Nizar M. Tannir, Sabina Signoretti, Toni K. Choueiri, et al. Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma. Clin Cancer Res. In press. https://doi.org/10.1158/1078-0432.ccr-20-2063
|
Rizzo, Alessandro |
|
|
3 |
6 |
p. 804-805 |
artikel |
19 |
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients
|
Pederzoli, Filippo |
|
|
3 |
6 |
p. 784-788 |
artikel |